Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania

Sponsor
University of California, Berkeley (Other)
Overall Status
Completed
CT.gov ID
NCT01957917
Collaborator
National Institute of Mental Health (NIMH) (NIH), Ministry of Health and Social Welfare, Tanzania (Other)
800
4
3
69.4
200
2.9

Study Details

Study Description

Brief Summary

The importance of good nutrition and food security among people living with HIV infection (PLHIV) is widely recognized. In resource-constrained settings, food insecurity is increasingly recognized as an important barrier to retention in care and adherence to antiretroviral therapy (ART). However, there are few studies demonstrating that food and nutrition assistance programs can improve HIV-related outcomes. This study will address this gap by comparing the effectiveness of three models for short-term support for PLHIV. Food insecure women and men on ART will be randomized into one of three groups: 1) nutrition assessment and counseling (NAC) alone, 2) NAC plus food assistance, or 3) NAC plus cash transfers. The investigators will compare the effect of the three approaches on ART adherence and retention in care after 6, 12, and 24-36 months of follow-up. The investigators hypothesize that NAC plus short-term support in the form of food or cash assistance will result in better adherence to ART and retention in care than NAC alone, and that the effects of NAC plus food assistance will be the same as NAC plus cash assistance. The results from the study will provide evidence about which assistance modalities for PLHIV work best to improve ART adherence and retention in care, and under what conditions. This study will be conducted in Shinyanga Region, Tanzania, where approximately 17 percent of households have poor or borderline food consumption and 7.4 percent of people are living with HIV infection.

Condition or Disease Intervention/Treatment Phase
  • Other: NAC (Nutritional Assessment and Counseling)
  • Other: Cash Transfer
  • Other: Food Assistance
N/A

Detailed Description

The investigators will randomize 785 food insecure women and men who recently initiated ART (determined with the Household Hunger Scale1) into one of three groups: 1) NAC alone , 2) NAC plus food assistance, or 3) NAC plus cash transfers. Food assistance will be a standard food ration consisting of maize flour, groundnuts, and beans. The cash transfer will be the equivalent value as the food ration (approximately $13 USD/month). Participants will receive the monthly food ration or cash transfer for up to six months if they continue to receive monthly HIV care (the standard of care). The investigators will compare the effect of NAC and food or cash assistance to the effect of NAC alone on ART adherence and retention in care at 6, 12, and 24-36 months (Objective #1). The investigators will also compare the effectiveness of NAC plus food assistance and NAC plus cash transfers to determine if their effects are the same (Objective #2).

Study Design

Study Type:
Interventional
Actual Enrollment :
800 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Comparing Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania
Actual Study Start Date :
Dec 1, 2013
Actual Primary Completion Date :
Oct 1, 2016
Actual Study Completion Date :
Sep 12, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: NAC + Food Assistance

Arm 1 participants will receive NAC (nutritional assessment and counseling), plus a food ration once a month for 6 months if they continue their regular HIV care.

Other: NAC (Nutritional Assessment and Counseling)

Other: Food Assistance

Experimental: NAC + Cash Transfer

Arm 2 participants will receive NAC (nutritional assessment and counseling), plus a cash transfer equivalent in value to the food transfer once a month for 6 months if they continue their regular HIV care.

Other: NAC (Nutritional Assessment and Counseling)

Other: Cash Transfer

Active Comparator: NAC Only

Arm 3 participants will receive NAC (nutrition assessment and counseling) only, which is the standard of care at the selected health facilities.

Other: NAC (Nutritional Assessment and Counseling)

Outcome Measures

Primary Outcome Measures

  1. Change from baseline of Medication Possession Ratio (MPR) at 6 months and at 12 months [Baseline, 6 months, 12 months]

    ART adherence will be measured with the medication possession ratio (MPR), the proportion of time an individual is in possession of >1 ARV or prescription for ARV. MPR is computed as the number of days ARVs are prescribed or dispensed divided by the number of days in the interval, and has been shown to be associated with short-term virologic outcomes. We will determine the proportion of patients with MPR ≥95% in each of the study arms.

Secondary Outcome Measures

  1. Change from baseline in Food Security at 6 months and 12 months [Baseline, 6 months, 12 months]

    Food security will be measured with several validated scales: the Household Food Insecurity Access Scale (HFIAS), the Household Hunger Scale (HHS) and the Individual Dietary Diversity Scale (IDDS).

  2. Change from baseline in Viral Suppression at 6 months and 12 months [Baseline, 6 months, 12 months]

    viral load <400 copies/mL

  3. Change from baseline in ART adherence at 6 months, 12 months, and 24-36 months [Baseline, 6 months, 12 months, and 24-36 months]

    Proportion of patients who report taking at least 95% of prescribed doses in the previous month time frame. This will be measured by self-report.

  4. Change from baseline in Body Mass Index (BMI) at 6 months and 12 months [Baseline, 6, and 12 months]

    body weight in kilograms (kg) divided by height in meters squared

  5. Change from baseline in Weight at 6 months and 12 months [Baseline, 6 months, 12 months]

  6. Change from baseline of Medication Possession Ratio (MPR) at 12-36 months [12-36 months]

    ART adherence will be measured with the medication possession ratio (MPR), the proportion of time an individual is in possession of >1 ARV or prescription for ARV. MPR is computed as the number of days ARVs are prescribed or dispensed divided by the number of days in the interval, and has been shown to be associated with short-term virologic outcomes. We will determine the proportion of patients with MPR ≥95% in each arm.

  7. Retention in Care at 12-36 months [12-36 months]

    Retention in care will be assessed by number of participants in each arm that are still still in care at 12-36 months

Other Outcome Measures

  1. Change from baseline in ability to work/participation in the labor force at 6 months and 12 months [Baseline, 6 months, 12 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. at least 18 years of age;

  2. living with HIV infection;

  3. initiated antiretroviral therapy (ART) for HIV infection in the last 90 days;

  4. food insecure, as measured with the Household Hunger Scale; and

  5. willing and able to provide written informed consent for the study.

Exclusion Criteria:

PLHIV who are severely malnourished (BMI<18.5) will be excluded from the study, as these individuals require therapeutic food support (ready-to-use food products for nutritional recovery). In this study, we will enroll food insecure PLHIV who are at risk of malnutrition but are not severely malnourished (BMI>18.5).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kahama District Hospital Shinyanga Shinyanga Region Tanzania
2 Kambarage Health Center Shinyanga Shinyanga Region Tanzania
3 Kishapu Health Center Shinyanga Shinyanga Region Tanzania
4 Shinyanga Regional Hospital Shinyanga Shinyanga Region Tanzania

Sponsors and Collaborators

  • University of California, Berkeley
  • National Institute of Mental Health (NIMH)
  • Ministry of Health and Social Welfare, Tanzania

Investigators

  • Principal Investigator: Sandra I McCoy, PhD, University of California, Berkeley

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sandra McCoy, Assistant Adjunct Professor, University of California, Berkeley
ClinicalTrials.gov Identifier:
NCT01957917
Other Study ID Numbers:
  • 5K01MH094246
  • 5K01MH094246
First Posted:
Oct 8, 2013
Last Update Posted:
Mar 31, 2020
Last Verified:
Mar 1, 2020
Keywords provided by Sandra McCoy, Assistant Adjunct Professor, University of California, Berkeley
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2020